Catalyst Wire Dossier Catalyst Wire Dossier

ECF (Epirubicin, Cisplatin, 5-FU)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ECF (Epirubicin, Cisplatin, 5-FU), covering 2019-06-19 to 2019-06-19. Get the full timeline:

Most recent: Clinical Trial Update: 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Phase 2, Phase 3]

See pricing